Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for juvenile idiopathic inflammatory myopathy has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include biologic therapy. Pipeline includes 1 PHASE2. Research is primarily industry-sponsored.
10 publications have been identified in PubMed for juvenile idiopathic inflammatory myopathy. Research spans Epidemiology / Natural History (50%), Review / Meta-Analysis (30%), and Diagnostic / Biomarker (10%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 5 | 50% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 7:04 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 3 | 30% |
Testing and diagnosis research | 1 | 10% |
Laboratory research | 1 | 10% |
Kaneko S (2026). [PMID: 41240467](https://pubmed.ncbi.nlm.nih.gov/41240467/). *Cytokine*. [Basic Science / Preclinical]
Wang CL (2026). [PMID: 41803247](https://pubmed.ncbi.nlm.nih.gov/41803247/). *Pediatric research*. [Epidemiology / Natural History]
Ge G (2026). [PMID: 41834211](https://pubmed.ncbi.nlm.nih.gov/41834211/). *Zhonghua er ke za zhi = Chinese journal of pediatrics*. [Review / Meta-Analysis]
Tsuji H (2025). [PMID: 40368794](https://pubmed.ncbi.nlm.nih.gov/40368794/). *Internal medicine (Tokyo, Japan)*. [Epidemiology / Natural History]
Guo JC (2025). [PMID: 40374515](https://pubmed.ncbi.nlm.nih.gov/40374515/). *The Journal of rheumatology*. [Review / Meta-Analysis]
Baskan AK (2025). [PMID: 41306012](https://pubmed.ncbi.nlm.nih.gov/41306012/). *Pediatric pulmonology*. [Diagnostic / Biomarker]
Loganathan A (2024). [PMID: 38479813](https://pubmed.ncbi.nlm.nih.gov/38479813/). *Rheumatology (Oxford, England)*. [Epidemiology / Natural History]
Nossent J (2024). [PMID: 39420796](https://pubmed.ncbi.nlm.nih.gov/39420796/). *International journal of rheumatic diseases*. [Epidemiology / Natural History]
Kobayashi I (2024). [PMID: 39334579](https://pubmed.ncbi.nlm.nih.gov/39334579/). *Children (Basel, Switzerland)*. [Review / Meta-Analysis]
Tsuji H (2024). [PMID: 39142036](https://pubmed.ncbi.nlm.nih.gov/39142036/). *Seminars in arthritis and rheumatism*. [Epidemiology / Natural History]
AI-curated news mentioning juvenile idiopathic inflammatory myopathy
Updated May 21, 2026
A new study presents a non-invasive model combining serum KL-6 levels and lung ultrasound B-lines to screen and predict interstitial lung disease in patients with idiopathic inflammatory myopathy. This approach could enhance early detection and management of lung complications in this patient population.
The JIR-CliPS network focuses on developing real-life clinical practice strategies for juvenile inflammatory rheumatism. This initiative aims to enhance the management and treatment of this condition through collaborative methodologies.